Archives: Projects/Publication

Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium

Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium

Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium

Williams, K., Verhoeven, V., Cumberland, P., Bertelsen, G., Wolfram, C., Buitendijk, G., Hofman, A., Duijn, C., Vingerling, J., Kuijpers, R., Höhn, R., Mirshahi, A., Khawaja, A., Luben, R., Erke, M., Hanno, T., Mahroo, O., Hogg, R., Gieger, C., Cougnard-Grégoire, A., Anastasopoulos, E., Bron, A., Dartigues, J., Korobelnik, J., Creuzot-Garcher, C., Topouzis, F., Delcourt, C., Rahi, J., Meitinger, T., Fletcher, A., Foster, P., Pfeiffer, N., Klaver, C., Hammond, C.

European Journal of Epidemiology DOI: 10.1007/s 10654-015-0010-0

2015

Screening for Diabetic Retinopathy in the Central Region of Portugal. Added Value of Automated ‘Disease/No Disease’ Grading

Screening for Diabetic Retinopathy in the Central Region of Portugal. Added Value of Automated ‘Disease/No Disease’ Grading

Screening for Diabetic Retinopathy in the Central Region of Portugal. Added Value of Automated ‘Disease/No Disease’ Grading

Ribeiro L, · Oliveira CM, · Neves C, · Ramos JD, · Ferreira H, · Cunha-Vaz J

Ophthalmologica 2015;233(2):96–103 DOI: 10.1159/000368426

2015

Safety monitoring of ophthalmic biologics: analysis of pre and post-marketing safety data.

Safety monitoring of ophthalmic biologics: analysis of pre and post-marketing safety data.

Safety monitoring of ophthalmic biologics: analysis of pre and post-marketing safety data.

Penedones A, Mendes D, Alves C, Batel Marques F.

Journal of Ocular Pharmacology and Therapeutics. 2014 doi:10.1089/jop.2013.0206

2014
http://www.ncbi.nlm.nih.gov/pubmed/25073069

Implemented Data Mining and Signal Management Systems on Spontaneous Reporting Systems’ Databases and their Availability to the Scientific Community – A Systematic Review

Implemented Data Mining and Signal Management Systems on Spontaneous Reporting Systems’ Databases and their Availability to the Scientific Community – A Systematic Review

Implemented Data Mining and Signal Management Systems on Spontaneous Reporting Systems’ Databases and their Availability to the Scientific Community – A Systematic Review

Lima LMAV, Craveiro N, Dias PGP Batel Marques F

Current Drug Safety 2012; 7(2):170-175

2012
http://www.ncbi.nlm.nih.gov/pubmed/22873501

Microaneurysm turnover in the macula is a biomarker for the development of clinically significant macular edema in diabetes type 2

Microaneurysm turnover in the macula is a biomarker for the development of clinically significant macular edema in diabetes type 2

Microaneurysm turnover in the macula is a biomarker for the development of clinically significant macular edema in diabetes type 2

Ribeiro L.; Nunes S.; Cunha-Vaz J.

Current Biomarker Findings 2013:3 11-15

2013

Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.

Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.

Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.

Ribeiro, M.L., Nunes, S.G., Cunha-Vaz, J.

DIABETES CARE 2013, DOI:10.2337/DC12–1491

2013

Macular Thickness Measured by Stratus OCT in patients with Diabetes Type 2 and Mild Nonproliferative Retinopathy without Clinical evidence of Macular Edema.

Macular Thickness Measured by Stratus OCT in patients with Diabetes Type 2 and Mild Nonproliferative Retinopathy without Clinical evidence of Macular Edema.

Macular Thickness Measured by Stratus OCT in patients with Diabetes Type 2 and Mild Nonproliferative Retinopathy without Clinical evidence of Macular Edema.

Pires I.; Santos, A.; Nunes S.; Lobo C.

Ophthalmologica 2013; 229(4):181-186.

2013

Three Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Clinically Significant Macular Edema

Three Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Clinically Significant Macular Edema

Three Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Clinically Significant Macular Edema

Nunes S.; Ribeiro L.; Fonseca M.; Cunha-Vaz J.

DOI: 10.1167/iovs.13-11895

2013